Back

Increased clot strength following transcatheter aortic valve replacement

25 August 2023 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Can we prevent strokes during TAVI? Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor David Hesselbarth

University Heart Center Freiburg-Bad Krozingen, Freiburg (Germany)

6 More presentations in this session

Presentation thumbnail
Transcatheter versus surgical aortic valve replacement in patients with aortic stenosis: molecular pathways and correlation with clinical and echocardiographic parameters
Doctor D. Pedicino (Rome, IT) Doctor A. d'Aiello (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Acute ischemic stroke complicating tavi. predictors, outcomes, and treatment associated outcomes
Doctor M. Kheifets (Petah Tikva, IL)
Abstract Slides Video
Presentation thumbnail
Cerebral embolic protection devices during transcatheter aortic valve implantation: a meta-analysis of randomised controlled trials.
Doctor R. Reddy (Durham, US)
Abstract Slides Video
Presentation thumbnail
Cerebral embolic protection in transcatheter aortic valve replacement with bicuspid aortic stenosis
Doctor A. Gupta (Los Angeles, US)
Abstract Slides Video
Presentation thumbnail
Effectiveness of Cerebral Embolic Protection in Transcatheter Aortic Valve Replacement with High Aortic Valve Calcium Burden
Doctor A. Gupta (Los Angeles, US)
Abstract Slides Video

Access the full session

Session thumbnail
Can we prevent strokes during TAVI?

The Event

Event poster

ESC Congress 2023

25 August 2023 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Thrombelastography identifies patients at risk for major adverse cardiovascular events after transcatheter aortic valve implantation
thumbnail
Congress Presentation
Hypercoagulability and inflammation indicate increased risk for hypoattenuated leaflet thickening in patients with transcatheter aortic valve replacement
thumbnail
Congress Presentation
Anticoagulatory treatment and clinical outcomes after transcatheter aortic valve implantation: results from 45,598 patients of the German Aortic Valve Registry (GARY)

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources